Cargando…

Diagnostic Ability of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prostate Cancer and Clinically Significant Prostate Cancer in Equivocal Lesions: A Systematic Review and Meta-Analysis

BACKGROUND: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) now has been used to diagnose prostate cancer (PCa). Equivocal lesions are defined as PIRADS category 3 or a Likert scale of 1 to 5 category 3 lesions. Currently, there are no clear recommendations for the management of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Jing, Cheng, Qingqing, Zhang, Dong, Fan, Meng, Shi, Changzheng, Luo, Liangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933498/ https://www.ncbi.nlm.nih.gov/pubmed/33680965 http://dx.doi.org/10.3389/fonc.2021.620628

Ejemplares similares

Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
por: Gaudiano, Caterina, et al.
Publicado: (2023)

Evaluating the Treatment Efficacy of Nano-Drug in a Lung Cancer Model Using Advanced Functional Magnetic Resonance Imaging
por: Huang, Cuiqing, et al.
Publicado: (2020)

Will Multi-Parametric Magnetic Resonance Imaging be the Future Tool to Detect Clinically Significant Prostate Cancer?
por: Giannarini, Gianluca, et al.
Publicado: (2014)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge
por: Gaudiano, Caterina, et al.
Publicado: (2023)

Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer
por: Preisser, Felix, et al.
Publicado: (2023)

The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
por: Cheng, Qingqing, et al.
Publicado: (2020)

MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
por: Schoots, Ivo G.
Publicado: (2018)

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer
por: Pang, Xinnian, et al.
Publicado: (2022)

A novel approach for automatic segmentation of prostate and its lesion regions on magnetic resonance imaging
por: Ren, Huipeng, et al.
Publicado: (2023)

Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer
por: Zhou, Yongheng, et al.
Publicado: (2022)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

Equivocal test results and prognostic staging uncertainties in the evaluation of patients with cancer of the prostate.
por: Clemens, J. D., et al.
Publicado: (1986)

Radiomics Based on Multiparametric Magnetic Resonance Imaging to Predict Extraprostatic Extension of Prostate Cancer
por: Xu, Lili, et al.
Publicado: (2020)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
por: Huang, Chen, et al.
Publicado: (2022)

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques
por: Anttinen, Mikael, et al.
Publicado: (2022)

Magnetic resonance imaging-guided ultrasound ablation for prostate cancer – A contemporary review of performance
por: Alabousi, Mostafa, et al.
Publicado: (2023)

Repeatability of Quantitative Imaging Features in Prostate Magnetic Resonance Imaging
por: Lu, Hong, et al.
Publicado: (2020)

Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
por: Li, Tianping, et al.
Publicado: (2022)

Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer
por: Hegde, John V, et al.
Publicado: (2018)

Simultaneous (18)F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
por: Esmaeili, Morteza, et al.
Publicado: (2018)

Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer
por: Hehakaya, Charisma, et al.
Publicado: (2020)

Improving the Diagnosis of Clinically Significant Prostate Cancer with Magnetic Resonance Imaging
por: De Visschere, Pieter
Publicado: (2018)

Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer
por: Ingole, Sarang M., et al.
Publicado: (2021)

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
por: Huebner, Nicolai Alexander, et al.
Publicado: (2020)

Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
por: Mo, Li-Cai, et al.
Publicado: (2022)

Magnetic Resonance Imaging in the Diagnosis of Mycetoma with Equivocal Clinical and Laboratory Features
por: Tarafdar, Swarnava, et al.
Publicado: (2022)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Prognostic significance of lncRNA AP004608.1 in prostate cancer
por: Li, Wei, et al.
Publicado: (2022)

Developing Strategy to Predict the Results of Prostate Multiparametric Magnetic Resonance Imaging and Reduce Unnecessary Multiparametric Magnetic Resonance Imaging Scan
por: Liu, Junxiao, et al.
Publicado: (2021)

Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging
por: Paydar, Ima, et al.
Publicado: (2015)

Comparison of machine learning models based on multi-parametric magnetic resonance imaging and ultrasound videos for the prediction of prostate cancer
por: Qi, Xiaoyang, et al.
Publicado: (2023)

Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer
por: Kim, Dong Gyun, et al.
Publicado: (2022)

Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers
por: Rouvière, Olivier, et al.
Publicado: (2017)

Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer
por: Paulino Pereira, Leonor Jane, et al.
Publicado: (2022)

Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
por: Noh, Tae Il, et al.
Publicado: (2023)

The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer
por: Shin, Teak Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s17gc54lake177udt349r79hsf